MANNKIND CORP Business Operations Contracts & Agreements

22 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Third Amendment to Supply Agreement, dated April 11, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc
Supply Agreements
MANNKIND CORP
Biotechnology
2024
Second Amendment to Supply Agreement, dated November 9, 2016, by and between MannKind and Amphastar Pharmaceuticals, Inc
Supply Agreements
MANNKIND CORP
Biotechnology
2024
License and Collaboration Agreement, dated September 3, 2018 by and between MannKind and United Therapeutics
Collaboration Agreements
MANNKIND CORP
Biotechnology
NY
2024
Fourth Amendment to Commercial Supply Agreement, dated December 22, 2022, by and between MannKind Corporation and United Therapeutics Corporation
Supply Agreements
MANNKIND CORP
Biotechnology
2023
Third Amendment to Commercial Supply Agreement, dated August 31, 2022, by and between MannKind Corporation and United Therapeutics Corporation
Supply Agreements
MANNKIND CORP
Biotechnology
2023
Second Amendment to Commercial Supply Agreement, dated June 15, 2022, by and between MannKind Corporation and United Therapeutics Corporation
Supply Agreements
MANNKIND CORP
Biotechnology
2023
First Amendment to Commercial Supply Agreement, dated October 16, 2021, by and between MannKind Corporation and United Therapeutics Corporation
Supply Agreements
MANNKIND CORP
Biotechnology
2021
Commercial Supply Agreement, dated August 12, 2021, by and between MannKind Corporation and United Therapeutics Corporation
Supply Agreements
MANNKIND CORP
Biotechnology
NY
2021
Supply Agreement, dated as of July 31, 2014, by and between MannKind and Amphastar France Pharmaceuticals S.A.S
Supply Agreements
MANNKIND CORP
Biotechnology
DE
2021
Fourth Amendment to Supply Agreement, dated December 24, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc
Supply Agreements
MANNKIND CORP
Biotechnology
2019
License and Collaboration Agreement, dated September 3, 2018 by and between MannKind and United Therapeutics Corporation
Collaboration Agreements
MANNKIND CORP
Biotechnology
NY
2018
Third Amendment to Supply Agreement, dated April 11, 2018, by and between MannKind and Amphastar Pharmaceuticals, Inc
Supply Agreements
MANNKIND CORP
Biotechnology
2018
Controlled Equity OfferingSM Sales Agreement, by and between MannKind and Cantor Fitzgerald & Co., dated February 27, 2018
Sales Agreements
MANNKIND CORP
Biotechnology
NY
2018
SECONDAMENDMENT TO SUPPLY AGREEMENT
Supply Agreements
MANNKIND CORP
Biotechnology
2017
FIRST AMENDMENT TO SUPPLY AGREEMENT
Supply Agreements
MANNKIND CORP
Biotechnology
2017
SETTLEMENT AGREEMENT
Settlement Agreements
MANNKIND CORP
Biotechnology
NY
2017
SUPPLY AGREEMENT
Supply Agreements
MANNKIND CORP
Biotechnology
NY
2014
SUPPLY AGREEMENT
Supply Agreements
MANNKIND CORP
Biotechnology
NY
2014
LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
MANNKIND CORP
Biotechnology
NY
2014
the risk of severe hypoglycemia, which is abnormally low levels of blood glucose that result from excessive insulin administration. Hypoglycemia can result in loss of mental...
Administration Agreements
MANNKIND CORP
Biotechnology
NY
2009
the risk of severe hypoglycemia, which is abnormally low levels of blood glucose that result from excessive insulin administration. Hypoglycemia can result in loss of mental...
Administration Agreements
MANNKIND CORP
Biotechnology
CT
2008
Supply Agreement dated December 31, 2004 between MannKind Corporation and Vaupell, Inc
Supply Agreements
MANNKIND CORP
Biotechnology
DE
2005